
Loading, please wait...

Loading, please wait...

Atrial fibrillation (AF) management has advanced significantly with the use of catheter ablation (CA). However, recent clinical reviews highlight that patient sex plays a critical role in long-term success. Emerging data suggest that female patients might experience a higher overall risk of AF recurrence after ablation compared to their male counterparts.
Researchers indicate that these differences do not stem from a single factor. Instead, they arise from a complex interplay of various biological and clinical elements. For example, fluctuating hormonal levels significantly impact cardiac electrophysiology. Furthermore, women often exhibit distinct patterns of cardiac remodeling, such as increased left atrial stiffness and lower strain. These structural changes can create a more complex substrate for arrhythmia. Additionally, clinical management trends show that women often receive ablation later in their disease course, which potentially influences procedural outcomes.
While the evidence points toward sex-based disparities, significant heterogeneity exists across various studies. Many current reports suffer from inconsistent endpoint definitions and inadequate adjustment for confounding variables. Consequently, these methodological gaps undermine the robustness of the current conclusions. Future prospective studies must use rigorous designs to test these hypotheses. Scholars emphasize the need for standardized follow-up protocols to better understand the trajectory of AF recurrence after ablation in diverse populations.
To improve patient outcomes, clinicians should move toward individualized, sex-sensitive management pathways. This approach includes precise preoperative assessments and substrate-guided ablation strategies. Enhanced postoperative monitoring specifically for women may also help in early detection and intervention. Ultimately, recognizing these sex-specific differences allows for more equitable and effective cardiovascular care.
Yes, several recent studies suggest that female patients may have a higher risk of recurrence. This trend is often attributed to older age at the time of the procedure and specific differences in cardiac remodeling substrates.
The differences arise from a combination of hormonal influences, electrophysiological characteristics, and unique patterns of atrial fibrosis. Clinical factors, such as delayed referral for ablation in women, also play a significant role.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship between the reader and the author. Refer to the latest local and national guidelines for clinical practice.
References
Cao Y et al. Sex differences in atrial fibrillation recurrence after catheter ablation: research status and progress. Biol Sex Differ. 2026 May 03. doi: 10.1186/s13293-026-00914-9. PMID: 42071251.
Teixeira R et al. Sex differences in atrial remodeling and atrial fibrillation recurrence after catheter ablation. Heart Rhythm. 2025 Sep 15. doi: 10.1016/j.hrthm.2025.02.003.
Jiang C et al. Sex Differences in Recurrence After linear Ablation for Persistent atrial fibrillation. Heart Rhythm. 2026 Feb 25. doi: 10.1016/j.hrthm.2026.02.025.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A narrative review highlights that women may face higher AF recurrence after ablation due to hormonal factors, cardiac remodeling, and management disparitie...
4 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today